Cargando…
Complement in malaria immunity and vaccines
Developing efficacious vaccines for human malaria caused by Plasmodium falciparum is a major global health priority, although this has proven to be immensely challenging over the decades. One major hindrance is the incomplete understanding of specific immune responses that confer protection against...
Autores principales: | Kurtovic, Liriye, Boyle, Michelle J., Opi, D. Herbert, Kennedy, Alexander T., Tham, Wai‐Hong, Reiling, Linda, Chan, Jo‐Anne, Beeson, James G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6972673/ https://www.ncbi.nlm.nih.gov/pubmed/31556468 http://dx.doi.org/10.1111/imr.12802 |
Ejemplares similares
-
Recent clinical trials inform the future for malaria vaccines
por: Kurtovic, Liriye, et al.
Publicado: (2021) -
Complement Factors in COVID-19 Therapeutics and Vaccines
por: Kurtovic, Liriye, et al.
Publicado: (2021) -
Antibody Targets and Properties for Complement-Fixation Against the Circumsporozoite Protein in Malaria Immunity
por: Kurtovic, Liriye, et al.
Publicado: (2021) -
Targets of complement-fixing antibodies in protective immunity against malaria in children
por: Reiling, Linda, et al.
Publicado: (2019) -
Human antibodies activate complement against Plasmodium falciparum sporozoites, and are associated with protection against malaria in children
por: Kurtovic, Liriye, et al.
Publicado: (2018)